Program – Day Two
The 4th WSC featured 16 sessions across 2 days, April 25 and 26, 2023. You can download the PDF program or explore day two below.
Session 7
The Benefits of Multidisciplinary Teams in Sepsis Care on the Health Care Facility Level
Moderated by:
Karn Cliffe
Dublin Midlands Hospital Group, Ireland
09:00h Berlin Time (CEST)
Impact of Sepsis Multidisciplinary Team Care on Patients Outcomes
Yaseen Arabi, Ministry of National Guard Health Affairs, Saudi Arabia
Initiation of Antimicrobial Stewardship in Resource-Constrained Environments: A Multidisciplinary Approach
Mirfin Mpundu, Director of ReAct Africa, Zambia
Sepsis Nurse – A Voice to Lead and Transform Care
Amanda Harley, Children’s Health Queensland, Australia
Family-Centered Care and Integration of Care Bundles
Kawaldip Sehmi, International Alliance of Patients’ Organization, United Kingdom
Early Rehabilitation in Sepsis: Journey to Return Activities and Functional Independence
Mohammed Alatwi, King Fahad Medical City, Saudi Arabia
Discussion by the Panelists
Session 8
The Potential and Challenges to Intervene with the Immune Response
Moderated by:
Nathan Nielsen
Global Sepsis Alliance, United States of America
10:30h Berlin Time (CEST)
The Impact of the Pathogen and the Host Response on Survival
Jennifer Muszynski, Nationwide Children’s, United States of America
Sepsis Immune Endotypes
Mihai Netea, Radboud UMC, The Netherlands
The Effect of Risk Stratification and Timing of Host-Directed Therapy
Evangelos J. Giamarellos-Bourboulis, European Sepsis Alliance, Greece
The Pros of Platform Trials
Eirini Christaki, University of Ioannina, Greece
The Cons of Platform Trials
Niels Riedemann, CEO InflaRx, Germany
Session 9
Biomarkers and Antimicrobial Stewardship – The Synergies to Diagnose Sepsis and to Prevent AMR
Moderated by:
Louise Thwaites
Global Sepsis Alliance, Vietnam
12:00h Berlin Time (CEST)
The Key Drivers of Antimicrobial Resistance
Silvia Bertagnolio, World Health Organization, Switzerland
The Potential and Barriers to Antibiotic Stewardship
Ron Daniels, Infection Management Coalition, United Kingdom
The Potential of Biomarkers for Antimicrobials – Use and Diagnosis
Evdoxia Kyriazopoulou, National and Kapodistrian University of Athens, Greece
The Role of Biomarkers for Risk Stratification
Peter Pickkers, Radboud UMC, The Netherlands
The Evidence for the Role of Transcriptional Diagnostics
Tom van der Poll, Amsterdam UMC, The Netherlands
Session 10
Lessons from the Pandemic to Fight Common Infections and Sepsis
Moderated by:
Detlev Ganten
Charité University Hospital, Germany
13:30h Berlin Time (CEST)
Learnings to Leverage the Fight Sepsis from an Integrated Health Service Perspective
Benedetta Allegranzi, World Health Organization, Switzerland
Preparing the EU to Manage Infections and Cross-Border Health Threats More Effectively
Velina Pendolovska, Directorate-General for Health and Food Safety, European Commission, Luxembourg
Lessons for Fighting Infections and Sepsis in Resource-Limited Settings
John Adabie Appiah, African Sepsis Alliance, Ghana
The Perspective of a Bedside Intensivist and the Potential of Telemedicine for Non-Covid Sepsis
Wiltrud Abels, Sepsis Stiftung, Germany
Learnings by a Caregiver and Researcher in Vietnam
Louise Thwaites, Asia Pacific Sepsis Alliance, Vietnam
Lessons for Clinical Research and Intensive Care Medicine
John Marshall, Unity Health, Canada
Discussion by the Panelists
Session 11
Understanding and Improving Long-term Outcomes After Sepsis and COVID-19
Moderated by:
Imrana Malik
Global Sepsis Alliance, United States of America
15:00h Berlin Time (CEST)
The Burden of Long-Term Consequences of Sepsis and COVID-19
Jamie Rylance, World Health Organization, Switzerland
What Is Known on the Pathogenesis of Long-Term Sequelae by Infections and Sepsis?
Joost Wiersinga, Amsterdam UMC, The Netherlands
Toward Tailored Care for Sepsis Survivors
Erin Carlton, University of Michigan, United States of America
How Can We Mitigate Post-Sepsis and Post-COVID-Morbidity?
Hallie Prescott, University of Michigan, United States of America
Translating Post-Sepsis Care to Post-COVID-19 Care – The Role of Healthcare Systems
Stephanie Taylor, University of Michigan, United States of America
Session 12
Neonatal Sepsis Platforms and Guidelines
Moderated by:
Odiraa Nwankwor
Sidney Kimmel Medical College, United States of America
16:30h Berlin Time (CEST)
Disproportionate Burden of AMR Excess Deaths Experienced by Neonates in Low- and Middle-Income Countries
Ramanan Laxminarayan, University of Washington, United States of America
Incidence and Burden of Neonatal Sepsis in South Africa
Vanessa Quan, National Institute for Communicable Diseases, South Africa
Neonatal Sepsis and Treatment Challenges in India
Jeeva Sankar, All India Institute Of Medical Sciences, India
Invasive Bloodstream Infections and AMR in Africa: Approaches to Treatment and Next Steps
Uduak Okomo, MRC Unit, The Gambia
Next Steps for NeoSep
Julia Bielicki, St George’s University of London, United Kingdom
Session 13
The Impact of Survivors and Family Members to Improve Sepsis Awareness and Advocacy
Moderated by:
Michael Clarke
European Sepsis Alliance, Belgium
18:00h Berlin Time (CEST)
Panel Discussion
Participants:
Ciarán Staunton, End Sepsis, United States of America
Melissa Mead, UK Sepsis Trust, United Kingdom
Ken Rothfield, Texas Health, United States of America
Luis Antonio Gorordo Del Sol, Sepsis Mexico, Mexico
Doireann O’Mahony, Irish Sepsis Foundation, Ireland
Mary Steele, Sepsis Australia Consumer Advocacy Group & Queensland Paediatric Sepsis Program, Australia
Session 14
Maternal Sepsis: Why Is It Still in the Top 3 for Global Incidence of Sepsis?
Moderated by:
Mercedes Bonet
World Health Organization, Switzerland
19:30h Berlin Time (CEST)
An Epidemiology-Based Assessment of the Problem
Alan Tita, University of Alabama at Birmingham, United States of America
Sharing the Story
Video
Sepsis Awareness and the Importance of Advocacy – Perspective of a Midwife and Sepsis Survivor
Helen Cheyne, University of Stirling, United Kingdom
Early Detection and Management – What Does It Mean for Maternal Sepsis?
Maria Fernanda Escobar Vidarte, The International Federation of Gynecology and Obstetrics, Colombia
Can Changing the Health System’s Approach Improve Maternal Sepsis Outcomes in Argentina and Beyond?
Edgardo Abalos, Independent Researcher, Argentina
Can Changing the Health System’s Approach Improve Maternal Sepsis Outcomes in Lebanon and Beyond?
Sabina Abou Malham, Université de Sherbrooke, Canada
Discussion by the Panelists
The Perspective of the World Health Organization
Benedetta Allegranzi, World Health Organization, Switzerland
Session 15
Harnessing the Media to Advance the Global Fight Against Sepsis
Moderated by:
Lord Michael Grade
House of Lords, United Kingdom
21:00h Berlin Time (CEST)
Healthcare in the Media: The Good, The Bad, and The Ugly
Katelyn Jetelina, Your Local Epidemiologist, United States of America
How to Target Specific Audiences for Improved Medical Messaging About Sepsis
Joachim Mueller-Jung, Science editor-in-chief, Frankfurter Allgemeine Zeitung, Germany
Effective Strategies for Better Medical Messaging in Media: Asia-Pacific
Naoyuki Matsuda, Global Sepsis Alliance, Japan
Effective Strategies for Better Medical Messaging in Media: Sub-Saharan Africa
Pedmia Shatu Tita, Global Initiative for Digital Inclusion and Communication, Cameroon
What Is the Role of the Journalist in Amplifying Positive Medical Messaging
Immaculate Forgwe, National Polytechnic Bamenda, Cameroon
Session 16
An Update on Research on Sepsis
Moderated by:
Flavia Machado
Latin American Sepsis Institute, Brazil
22:30h Berlin Time (CEST)
Why Criteria for Diagnosing Pediatric Sepsis and the Social Determinants of Health Matter
Kusum Menon, University of Ottawa, Canada
Impact of Time to Source Control on Sepsis Mortality
Katherine Reitz, University of Pittsburgh Medical Center, United States of America
Does Rapid Sepsis Treatment Increase the Risk of Antimicrobial Resistance?
Hallie Prescott, University of Michigan, United States of America
Intravenous Vitamin C in Sepsis: the LOVIT Study
François Lamontagne, Université de Sherbrooke, Canada
Balanced Crystalloids or Saline for Sepsis?
Naomi Hammond, The George Institute for Global Health, Australia
Restrictive or Liberal Fluid in Sepsis: the CLOVERS Study
Ivor Douglas, Denver Health, United States of America
Closing Remarks: Imrana Malik, Program Chair & GSA Executive Member, United States of America